Loading...

Caris Life Sciences, Inc.

CAINASDAQ
Healthcare
Biotechnology
$29.54
$0.05(0.17%)

Caris Life Sciences, Inc. (CAI) Company Profile & Overview

Explore Caris Life Sciences, Inc.’s business operations, leadership, sector classification, and key company facts including IPO date, industry, and contact details.

Caris Life Sciences, Inc. (CAI) Company Profile & Overview

Caris Life Sciences, Inc., an artificial intelligence TechBio company, provides molecular profiling services in the United States and internationally. It develops and commercializes solutions to transform healthcare using molecular information, and machine learning algorithms. The company's molecular profiling services portfolio includes MI Profile, a tissue-based molecular profiling solution; and Caris Assure, a blood-based molecular profiling solution for cancer treatment. It also offers pharma research and development services comprising laboratory delivery, strategic data, and research services to biopharmaceutical customers. The company was founded in 2008 and is headquartered in Irving, Texas.

SectorHealthcare
IndustryBiotechnology
CEODavid Dean Halbert

Contact Information

866 771 8946
750 West John Carpenter Freeway, Irving, TX, 75039

Company Facts

1,769 Employees
IPO DateJun 18, 2025
CountryUS
Actively Trading

Frequently Asked Questions

;